Top Story

Allergan to acquire Oculeve in all-cash transaction

July 6, 2015

Allergan and Oculeve have entered into an agreement under which Allergan will acquire Oculeve in an all-cash transaction, according to press release from Allergan.

Under this agreement, Allergan will acquire Oculeve for an upfront payment of $125 million and commercialization milestone payments related to Oculeve’s OD-01, a noninvasive nasal neurostimulation device that increases tear production in patients with dry eye disease.

BLOG: Trocar anterior chamber maintainer for infusion BlogVideo

BLOG: Trocar anterior chamber maintainer for infusion

July 6, 2015
Maintenance of continuous infusion in the eye is an important consideration in many complicated intraocular surgeries.Anterior segment surgeons mostly use an anterior…
VIDEO: A novel approach to ab interno trabeculotomy Meeting News CoverageVideo

VIDEO: A novel approach to ab interno trabeculotomy

July 6, 2015
At the Kiawah Eye 2015 meeting, Savak "Sev" Teymoorian, MD, MBA, discusses ab interno trabeculotomy using the TRAB360 trabeculotomy instrument (Sight Sciences).
VIDEO: Speaker gives pearls for treating cataract and retinal diseases Meeting News CoverageVideo

VIDEO: Speaker gives pearls for treating cataract and retinal diseases

July 5, 2015
At the Kiawah Eye 2015 meeting, John D. Hyatt, MD, discusses important information for the comprehensive ophthalmologist to know when treating cataract and retinal…
VIDEO: Update on the diagnosis and management of meibomian gland dysfunction Meeting News CoverageVideo

VIDEO: Update on the diagnosis and management of meibomian gland dysfunction

July 4, 2015
At the Kiawah Eye 2015 meeting, Heather M. Skeens, MD, discusses the diagnosis and treatment of meibomian gland dysfunction.
More News Headlines »
Practical Retina

Comparing Aflibercept, Bevacizumab, and Ranibizumab for DME: Analysis of DRCR Protocol T

Ophthalmic Surgery, Lasers and Imaging Retina, March 2015, Volume 46 Issue 3
More »
CME
Real-world Use of Anti-VEGF Therapy

Real-world Use of Anti-VEGF Therapy

This activity is supported by an educational grant from Genentech, Inc.

Anti-VEGF is well established as first-line therapy for the treatment of diabetic macular edema (DME) and age-related…
More »
Meeting News Coverage Video
VIDEO: Speaker gives pearls for treating cataract and retinal diseases

VIDEO: Speaker gives pearls for treating cataract and retinal diseases

July 5, 2015
At the Kiawah Eye 2015 meeting, John D. Hyatt, MD, discusses important information for the comprehensive…
More »
morganatic-roan